Zota Health Care Ltd

Zota Health Care Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Zota Health Care Ltd

₹ 564 3.04%
22 Nov - close price
Company website NSE: ZOTA
About

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.[1]

Key Points

Business segments
Domestic sales (49% of FY21 revenue)[1] The is the oldest division and involves direct distribution of generic drugs, OTC products, and other pharmaceutical products through Company’s distribution network across India. Co. has 1050+ distributors across India and 3000+ products in its portfolio.

Website NSE
  • Market Cap ₹ 1,547 Cr.
  • Current Price ₹ 564
  • High / Low ₹ 725 / 402
  • Stock P/E 291
  • Book Value ₹ 80.1
  • Dividend Yield 0.18 %
  • ROCE 4.56 %
  • ROE 3.13 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has been maintaining a healthy dividend payout of 50.1%

Cons

  • Stock is trading at 7.04 times its book value
  • Promoter holding has decreased over last quarter: -2.03%
  • Company has a low return on equity of 7.20% over last 3 years.
  • Company has high debtors of 162 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Trading Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
35.40 30.94 31.75 29.49 38.57 34.05 36.26 35.25 41.15 42.83 47.35 52.20 59.01
30.47 25.78 31.38 27.42 33.34 33.91 35.68 34.64 38.06 40.71 46.97 49.25 55.77
Operating Profit 4.93 5.16 0.37 2.07 5.23 0.14 0.58 0.61 3.09 2.12 0.38 2.95 3.24
OPM % 13.93% 16.68% 1.17% 7.02% 13.56% 0.41% 1.60% 1.73% 7.51% 4.95% 0.80% 5.65% 5.49%
0.18 0.34 0.82 0.54 0.98 0.80 0.77 0.36 0.63 0.38 0.69 0.47 0.97
Interest 0.01 0.01 0.04 0.02 0.03 0.01 0.01 0.05 0.25 0.00 0.06 0.42 0.52
Depreciation 0.66 0.76 0.70 0.56 0.57 0.62 0.66 0.55 0.77 0.83 0.86 0.68 0.73
Profit before tax 4.44 4.73 0.45 2.03 5.61 0.31 0.68 0.37 2.70 1.67 0.15 2.32 2.96
Tax % 25.23% 25.16% 22.22% 27.59% 24.78% 19.35% 1.47% 43.24% 33.70% 30.54% -46.67% 31.90% 20.61%
3.32 3.54 0.35 1.46 4.22 0.25 0.65 0.21 1.79 1.16 0.22 1.58 2.35
EPS in Rs 1.32 1.41 0.14 0.58 1.68 0.10 0.26 0.08 0.69 0.45 0.09 0.60 0.86
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
43 49 56 64 70 77 85 95 106 131 138 166 201
37 43 47 55 60 66 77 90 105 116 130 160 193
Operating Profit 6 7 8 10 10 11 8 5 1 15 8 6 9
OPM % 14% 13% 15% 15% 14% 14% 9% 5% 1% 12% 6% 4% 4%
0 0 0 0 0 2 2 2 2 2 3 2 3
Interest 1 1 1 1 1 0 0 0 0 0 0 0 1
Depreciation 1 1 2 1 1 1 1 2 3 3 2 3 3
Profit before tax 4 5 6 8 8 11 8 4 -0 14 9 5 7
Tax % 32% 33% 33% 34% 34% 36% 29% 29% -47% 25% 24% 31%
3 3 4 5 6 7 6 3 -0 11 7 3 5
EPS in Rs 1.52 1.86 2.12 2.54 2.76 2.96 2.26 1.12 -0.07 4.21 2.62 1.31 2.00
Dividend Payout % 47% 38% 34% 28% 52% 72% 32% 89% -1,535% 36% 38% 76%
Compounded Sales Growth
10 Years: 13%
5 Years: 14%
3 Years: 16%
TTM: 37%
Compounded Profit Growth
10 Years: 1%
5 Years: -9%
3 Years: 72%
TTM: 120%
Stock Price CAGR
10 Years: %
5 Years: 25%
3 Years: 16%
1 Year: 41%
Return on Equity
10 Years: 8%
5 Years: 5%
3 Years: 7%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 12 12 14 14 14 18 18 25 25 25 25 26 27
Reserves 2 4 4 7 13 52 51 44 42 66 69 96 192
5 5 5 2 4 0 0 0 0 0 0 15 0
10 13 15 20 23 22 21 20 19 34 30 37 45
Total Liabilities 29 33 38 44 54 92 90 88 86 125 125 173 265
9 9 8 7 7 10 10 15 14 13 11 12 62
CWIP 0 0 0 1 2 0 2 0 0 0 3 5 5
Investments 0 0 0 0 0 26 16 14 10 35 10 7 0
20 24 30 36 45 56 63 59 62 78 101 150 197
Total Assets 29 33 38 44 54 92 90 88 86 125 125 173 265

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
3 3 4 5 3 -4 -3 6 -1 14 -10 -30
-1 -1 -1 -1 -2 -26 9 -4 4 -27 13 -9
-2 -2 -4 -3 -2 33 -6 -3 -2 14 -4 38
Net Cash Flow 0 0 0 1 -1 2 -1 -1 1 1 -1 -1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 71 79 77 90 88 109 95 112 99 107 115 162
Inventory Days 132 134 175 141 193 174 207 139 139 116 148 139
Days Payable 86 104 116 126 148 118 103 82 77 76 102 107
Cash Conversion Cycle 117 108 135 105 133 165 199 169 161 147 161 194
Working Capital Days 86 74 87 85 115 151 175 152 143 112 153 204
ROCE % 24% 27% 32% 36% 33% 23% 11% 6% -2% 18% 9% 5%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
68.09% 68.11% 68.12% 68.12% 68.12% 68.12% 68.12% 66.16% 66.15% 66.15% 64.44% 62.40%
0.00% 0.00% 0.00% 0.07% 0.00% 0.00% 0.04% 0.02% 0.00% 0.00% 0.01% 0.01%
0.34% 0.30% 0.45% 0.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.99%
31.57% 31.59% 31.43% 31.75% 31.88% 31.88% 31.84% 33.83% 33.85% 33.85% 35.55% 36.60%
No. of Shareholders 7,2557,8178,1497,8667,9567,2337,1077,2857,5897,4357,6618,937

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Aug 2024
    Transcript
    Notes
    PPT
  • May 2024
    Transcript
    Notes
    PPT
  • Feb 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Jun 2023
    Transcript
    Notes
    PPT
  • Feb 2023
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT
  • Sep 2022
    Transcript
    Notes
    PPT
  • Jun 2022
    Transcript
    Notes
    PPT
  • Feb 2022
    Transcript
    Notes
    PPT
  • Dec 2021
    Transcript
    Notes
    PPT
  • Aug 2021
    Transcript
    Notes
    PPT
  • Jun 2021
    Transcript
    Notes
    PPT
  • Feb 2021
    Transcript
    Notes
    PPT
  • Dec 2020
    Transcript
    Notes
    PPT
  • Sep 2020
    Transcript
    Notes
    PPT
  • Jun 2020
    Transcript
    Notes
    PPT
  • Feb 2020
    Transcript
    Notes
    PPT